Cystatin C as an index of acute cerebral infraction recurrence: one-year follow-up study

References

• Liu M, Wu B, Wang WZ, et al. Stroke in China: epidemiology, prevention, and management strategies. Lancet Neurol. 2007;6(5):456–464.
   PubMed Web of Science ®Google Scholar
• Zhang ZG, Wang C, Wang J, et al. Prognostic value of mannose-binding lectin: 90-day outcome in patients with acute ischemic stroke. Molecular Neurobiol. 2015;51(1):230–239.
   PubMed Web of Science ®Google Scholar
• Li B, Lou Y, Gu H, et al. Trends in incidence of stroke and transition of stroke subtypes in rural Tianjin China: a population-based study from 1992 to 2012. PLoS One. 2015;10(10):e0139461.
   Web of Science ®Google Scholar
• Zeng Q, Lin K, Yao M, et al. Significant correlation between cystatin C, cerebral infarction, and potential biomarker for increased risk of stroke. Curr Neurovasc Res. 2015;12(1):40–46.
   PubMed Web of Science ®Google Scholar
• Filler G, Bokenkamp A, Hofmann W, et al. Cystatin C as a marker of GFR - history, indications, and future research. Clin Biochem. 2005;38(1):1–8.
   PubMed Web of Science ®Google Scholar
• Kleber ME, Goliasch G, Grammer TB, et al. Evolving biomarkers improve prediction of long-term mortality in patients with stable coronary artery disease: the BIO-VILCAD score. J Int Med. 2014;276(2):184–194.
   PubMed Web of Science ®Google Scholar
• Negrusz-Kawecka M, Porpeba R, Hulok A, et al. Evaluation of the significance of cystatin C levels in patients suffering from coronary artery disease. Adv Clin Exp Med. 2014;23(4):551–558.
   PubMed Web of Science ®Google Scholar
• Yang B, Zhu J, Miao Z, et al. Cystatin C is an independent risk factor and therapeutic target for acute ischemic stroke. Neurotox Res. 2015;28(1):1–7.
   PubMed Web of Science ®Google Scholar
• Wada M, Nagasawa H, Kawanami T, et al. Cystatin C as an index of cerebral small vessel disease: results of a cross-sectional study in community-based Japanese elderly. Eur J Neurol. 2010;17(3):383–390.
   PubMed Web of Science ®Google Scholar
• Chen PH, Gao S, Wang YJ, et al. Classifying ischemic stroke, from TOAST to CISS. Cns Neurosci Ther. 2012;18(6):452–456.
   PubMed Web of Science ®Google Scholar
• Mohan KM, Wolfe CDA, Rudd AG, et al. Risk and cumulative risk of stroke recurrence a systematic review and meta-analysis. Stroke. 2011;42(5):1489–1494.
   PubMed Web of Science ®Google Scholar
• Zhao DQ, Pan SY, Chen JH, et al. Relationship between cystatin C and cerebral infarction. Nan fang yi ke da xue xue bao = J South Med Univ. 2009;29(4):807–808.
   PubMedGoogle Scholar
• Maier IL, Bauerle M, Kermer P, et al. Risk prediction of very early recurrence, death and progression after acute ischaemic stroke. Eur J Neurol. 2013;20(4):599.
   PubMed Web of Science ®Google Scholar
• Ni L, Lue J, Hou LB, et al. Cystatin C, associated with hemorrhagic and ischemic stroke, is a strong predictor of the risk of cardiovascular events and death in Chinese. Stroke. 2007;38(12):3287–3288.
   Google Scholar
• Yaffe K, Lindquist K, Shlipak MG, et al. Cystatin C as a marker of cognitive function in elders: findings from the health ABC study. Ann Neurol. 2008;63(6):798–802.
   PubMed Web of Science ®Google Scholar
• Ito R, Yamakage H, Kotani K, et al. Comparison of cystatin C- and creatinine-based estimated glomerular filtration rate to predict coronary heart disease risk in Japanese patients with obesity and diabetes. Endocr J. 2015;62(2):201–207.
   PubMed Web of Science ®Google Scholar
• Kopitar-Jerala N. The role of cystatins in cells of the immune system. FEBS Lett. 2006;580(27):6295–6301.
   PubMed Web of Science ®Google Scholar
• Rule AD, Larson TS, Bergstralh EJ, et al. Using serum creatinine to estimate glomerular filtration rate: Accuracy in good health and in chronic kidney disease. Ann Int Med. 2004;141(12):929–937.
   PubMed Web of Science ®Google Scholar
• Coll E, Botey A, Alvarez L, et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis. 2000;36(1):29–34.
   PubMed Web of Science ®Google Scholar
• Iguchi Y, Kimura K, Kobayashi K, et al. Relation of atrial fibrillation to glomerular filtration rate. Am J Cardiol. 2008;102(8):1056–1059.
   PubMed Web of Science ®Google Scholar
• Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53(6):982–992.
   PubMed Web of Science ®Google Scholar
• Lee M, Saver JL, Huang W-H, et al. Impact of elevated cystatin C level on cardiovascular disease risk in predominantly high cardiovascular risk populations a meta-analysis. Circulat Cardiovasc Qual Outcomes. 2010;3(6):675–U189.
   PubMed Web of Science ®Google Scholar
• Xiao D, Liu H, Zhang H, et al. Impact of cystatin C levels on infarct size and hemorrhage volume in acute cerebral stroke. J Neurol. 2012;259(10):2053–2059.
   PubMed Web of Science ®Google Scholar
• Arpegard J, Oestergren J, de Faire U, et al. Cystatin C - A marker of peripheral atherosclerotic disease? Atherosclerosis. 2008;199(2):397–401.
   PubMed Web of Science ®Google Scholar
• Ferraro S, Marano G, Biganzoli EM, et al. Prognostic value of cystatin C in acute coronary syndromes: enhancer of atherosclerosis and promising therapeutic target. Clin Chem Lab Med. 2011;49(9):1397–1404.
   PubMed Web of Science ®Google Scholar
• Urbonaviciene G, Shi GP, Urbonavicius S, et al. Higher cystatin C level predicts long-term mortality in patients with peripheral arterial disease. Atherosclerosis. 2011;216(2):440–445.
   PubMed Web of Science ®Google Scholar
• Shi GP, Sukhova GK, Grubb A, et al. Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Investig. 1999;104(9):1191–1197.
   PubMed Web of Science ®Google Scholar
• Ikram MA, Vernooij MW, Hofman A, et al. Kidney function is related to cerebral small vessel disease. Neurology. 2008 ;70(11):A22–A22.
   Web of Science ®Google Scholar
• Seliger SL, Longstreth WT, Katz R, et al. Cystatin C and subclinical brain infarction. J Am Soc Nephrol. 2005;16(12):3721–3727.
   PubMed Web of Science ®Google Scholar
• Arboix A, Miguel M, Ciscar E, et al. Cardiovascular risk factors in patients aged 85 or older with ischemic stroke. Clin Neurol Neurosurg. 2006;108(7):638–643.
   PubMed Web of Science ®Google Scholar
• Tobin KAR, Holven KB, Retterstol K, et al. Cystatin C levels in plasma and peripheral blood mononuclear cells among hyperhomocysteinaemic subjects: effect of treatment with B-vitamins. Br J Nutr. 2009;102(12):1783–1789.
   PubMed Web of Science ®Google Scholar
• Yokokawa H, Goto A, Terui K, et al. Prevalence of metabolic syndrome and serum marker levels in patients with four subtypes of cerebral infarction in Japan. J Clin Neurosci. 2008;15(7):769–773.
   PubMed Web of Science ®Google Scholar
• IchiharaK, Saito K, Itoh Y. Sources of variation and reference intervals for serum cystatin C in a healthy Japanese adult population. Clin Chem Lab Med. 2007;45(9):1232–1236.
   Google Scholar
• Knight EL, Verhave JC, Spiegelman D, et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int. 2004;65(4):1416–1421.
   PubMed Web of Science ®Google Scholar
• Liu JA, Sukhova GK, Sun JS, et al. Lysosomal cysteine proteases in atherosclerosis. Arterioscler Thromb Vasc Biol. 2004;24(8):1359–1366.
   PubMed Web of Science ®Google Scholar